progression [5] [6] [7] [8] 
. Furthermore, we provide evidence that this up-regulation of BNP by inflammatory mediators is counteracted by fluvastatin, a 3-hydroxy-3-methylglutaryl-coenzyme-A-reductase inhibitor.

Materials and methods
Materials
Fluvastatin (kindly provided by Novartis, Basel, Switzerland) was handled as described previously [9] . (HACMs) were isolated, characterized and cultured as previously published [10] . More Fig. 1A and B) . In further analy- (Fig. 2A) . Furthermore, the increase in Nt-proBNP secretion by HACF induced by IL-1␣, TNF-␣ and TGF-␤, respectively, was reduced to Nt-proBNP levels seen in untreated control cells by the presence of 500 nM fluvastatin. A significant reduction of NtproBNP was also seen with 100 nM fluvastatin (Fig. 2B-D [12] . In this study, we provide evidence for the first time that similar to canine cardiac fibroblast [3] [13] . [5] [6] [7] [8] . Thus, one could speculate that BNP might not only reflect reduced ventricular function but also inflammatory and/or remodelling processes within the myocardium.
Recombinant human (rh) TNF-␣, rh IL-1␣, rh TGF-␤ were purchased from Roche (Basel, Switzerland) and rh IL-6, rh IL-11, rh oncostatin M (OSM) and rh leukaemia inhibitory factor (LIF) were purchased from R&D Systems (Minneapolis, MN).
Methods
Human adult cardiac fibroblasts (HACF) and human adult cardiac myocytes
Fig. 1 Effect of IL-1␣, TNF-␣, TGF-␤, IL-6, IL-11, OSM and LIF on proBNP production in HACF and HACM. Confluent monolayers of HACF (open bars) were incubated for 24 hrs with or without 2, 20 and 200 U/ml IL-1␣; 20, 200 and 2000 U/ml TNF-␣; or 0.5, 5 and 50 ng/ml TGF-␤, respectively (panel A). Confluent monolayers of HACM (hatched bars) were incubated for 24 hrs with or without 200 U/ml IL-1␣; or 2000 U/ml TNF-␣ (panel A). Confluent monolayers of HACF were incubated for 24 hrs with or without 100 ng/ml IL-6; 100 ng/ml IL-11; 10,000 U/ml LIF; or 100 ng/ml OSM, respectively (panel B). Nt-proBNP was determined in conditioned media using a specific ELISA and values are given in fmol/ml and represent mean values Ϯ S.D. of three independent determinations. Experiments were performed three times with cells isolated from three different donors. A representative experiment is
Results
Nt-proBNP concentration increased dose dependently in condition media of HACF treated with IL-1␣, TNF-␣ or TGF-␤, whereas IL-6, IL-11, OSM or LIF had no effect (
ses, we used the most effective concentrations of IL-1␣ (200 U/ml), TNF-␣ (2000 U/ml) or TGF-␤ (50 ng/ml). In addition, specific mRNA IL-1R1, IL-1R2, TGF-␤R1, TGF-␤2, TNFRSF1A, TNFRSF2A, gp130, IL-6R, IL-11R, OSMR and LIFR was detected in these cells by realtime PCR (data not shown
Discussion
Initial results on BNP production originate from in vitro data of cultivated neonatal rat cardiac myocytes. Limited data are, however, available on human myocardial cells
, cultured human adult cardiac fibroblasts also express BNP-mRNA and secrete BNP and that inflammatory mediators such as TNF-␣, IL-1-␣ and TGF-␤ are potent inducers of BNP mRNA expression and protein secretion by these cells. HACF also express the respective receptors for TNF-␣, IL-1-␣ and TGF-␤. Other inflammatory cytokines such as IL-6, IL-11, OSM or LIF did not affect BNP production in HACF. The respective receptors, however, were expressed by these cells. In contrast, human adult cardiac myocytes produced only 1/10 of the amount of BNP secreted by cardiac fibroblasts and BNP production in human cardiac myocytes was not affected by TNF-␣ or IL-1-␣. It should be emphasized that cultured rat cardiac myocytes produced only minute amounts of BNP as compared with mixed cultures of cardiac myocytes and non-myocytes. In addition, only these mixed cultures responded to IL-1 with a significant increase in BNP production
Fig. 2 Effect of TNF-␣, IL-1␣, TGF-␤ and fluvastatin on proBNP production in HACF. Confluent monolayers of HACF were incubated for 24 hrs without (panel A) or with 200 U/ml IL-1␣ (panel B), 2000 U/ml TNF-␣ (panel C) or 50 ng/ml TGF-␤ (panel
Statin therapy in patients with heart failure improves ventricular function and symptoms of heart failure and reduces ventricular dimensions as well as plasma concentrations of BNP, TNF-␣ and IL-6 independent of plasma cholesterol levels [14, 15] [16] . [17] . Indeed, statins have been shown to inhibit the prenylation of ROCK [18] [19] [20] . Of note, Rho is crucial for the activation of rac, which is involved in IL-1-dependent regulation of the human BNP promoter [21] . We show here that the [2] . On the other hand, BNP has been shown to enhance hypoxia-induced apoptosis of myocardial cells [23] , to have negative inotropic effects within the myocardium and to adversely affect cardiac contractility through inhibition of the expression of sarcoplasmic reticulum Ca 2ϩ ATPase [24, 25] . BNP also inhibits expression of several pro-inflammatory cytokines, which are essential to protect the heart against reperfusion injury and ischaemic myocardial damage [26, 27] , increases the expression of matrix metalloproteinases involved in remodelling [3] , promotes the accumulation of inflammatory cells in the infarcted myocardium [28] , suppresses the mitochondrial respiration in the myocardium, reduces the effects of catecholamines, induces systemic vasodilation and potentiates the generation of nitric oxide, which in turn is a known inhibitor of myocardial contractility [25, [29] [30] [31] [32] [33] . 
In our study, the inhibiting effect of fluvastatin on the IL-1␣-, TNF-␣-and TGF-␤-induced up-regulation of Nt-proBNP production by cardiac fibroblasts was completely reversed by mevalonate and GGPP, suggesting that this effect was brought about by inhibition of the mevalonic acid pathway and protein prenylation. In particular, GGPP is essential for the isoprenylation of the GTPases Rap, Rab and Rho. Blocking isoprenylation of these GTPases causes their inactivation and thus prevents ROCK signalling
ROCK inhibitor Y27632 inhibits the IL-1␣-, TNF-␣-and TGF-␤-induced up-regulation of Nt-proBNP similarly to fluvastatin. These results suggest that fluvastatin exerts its effect on IL-1␣-, TNF-␣-and TGF-␤-induced up-regulation of
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